Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117322) titled 'To Evaluate the Efficacy and Safety of Livomyn FL Tablets in Adults with Metabolic Dysfunction Associated Steatotic Liver Disease' on Sept. 9.

Study Type: Interventional

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable

Primary Sponsor: Charak Pvt.Ltd.

Condition: Health Condition 1: K77- Liver disorders in diseases classified elsewhere

Recruitment Status: Not Recruiting

Phase: Phase 4

Date of First Enrollment: 25-09-2026

Target Sample Size: 35

Countries of Recruitment:...